LifeStance Health Group, Inc.
LFST
$5.49
$0.091.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 345.31M | 332.97M | 325.48M | 312.72M | 312.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 345.31M | 332.97M | 325.48M | 312.72M | 312.33M |
| Cost of Revenue | 236.88M | 223.18M | 216.04M | 212.29M | 214.53M |
| Gross Profit | 108.43M | 109.79M | 109.44M | 100.43M | 97.81M |
| SG&A Expenses | 97.38M | 94.43M | 93.23M | 84.91M | 94.75M |
| Depreciation & Amortization | 14.01M | 13.76M | 14.67M | 15.12M | 18.60M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 348.26M | 331.37M | 323.94M | 312.32M | 327.87M |
| Operating Income | -2.95M | 1.60M | 1.54M | 405.00K | -15.54M |
| Income Before Tax | -5.94M | -1.47M | -8.88M | -5.38M | -22.62M |
| Income Tax Expenses | -2.15M | -2.18M | -1.76M | 575.00K | 656.00K |
| Earnings from Continuing Operations | -3.79M | 709.00K | -7.11M | -5.96M | -23.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.79M | 709.00K | -7.11M | -5.96M | -23.28M |
| EBIT | -2.95M | 1.60M | 1.54M | 405.00K | -15.54M |
| EBITDA | 11.06M | 15.36M | 16.21M | 15.52M | 3.06M |
| EPS Basic | -0.01 | 0.00 | -0.02 | -0.02 | -0.06 |
| Normalized Basic EPS | -0.01 | 0.00 | -0.01 | -0.01 | -0.04 |
| EPS Diluted | -0.01 | 0.00 | -0.02 | -0.02 | -0.06 |
| Normalized Diluted EPS | -0.01 | 0.00 | -0.01 | -0.01 | -0.04 |
| Average Basic Shares Outstanding | 386.73M | 383.27M | 380.45M | 380.36M | 379.43M |
| Average Diluted Shares Outstanding | 386.73M | 390.67M | 380.45M | 380.36M | 379.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |